Search

Displaying results 751 - 760 of 10000 in total
  1. Drug

    Pramipexole

    go.drugbank.com/drugs/DB00413
    ApprovedInvestigational

    Pramipexole is a drug used to treat the symptoms of Parkinson's Disease (PD). It is a non-ergot dopamine agonist drug that is efficacious in treating various Parkinson's symptoms such as tremor, rigidity, and bradykinesia (slow movement)...

    Categories: Heterocyclic Compounds, 1-RingProducts: PRADOSE 1 MG TABLET, 100 ADET, PEXA 1 MG TABLET, 100 ADET
  2. Drug

    Ornithine

    go.drugbank.com/drugs/DB00129
    ApprovedInvestigationalNutraceutical

    Produced during the urea cycle, ornithine is an amino acid produced from the splitting off of urea from arginine. L-Ornithine allows for the disposal of excess nitrogen and acts as a precursor of citrulline and arginine.

    Mixtures: PEDASEL %10 AMİNO ASİT ÇÖZELTİSİ, 100 ML, PRIMENE %10 İNFÜZYONLUK PEDİYATRİK AMİNOASİT ÇÖZELTİSİ, 100 MLProducts: HEPA-ORNITAT 5 G/10 ML INFÜZYON KONSANTRESI, 10 ADET, HEPA-MERZ INFUSION CONCENTRATE 5G/10 ML
  3. Drug

    Chlordiazepoxide

    go.drugbank.com/drugs/DB00475
    ApprovedIllicit

    An anxiolytic benzodiazepine derivative with anticonvulsant, sedative, and amnesic properties. It has also been used in the symptomatic treatment of alcohol withdrawal.

    Mixtures: LIBRAX DRAJE, 100 ADET, LIBRAX DRAJE, 40 ADETCategories: Heterocyclic Compounds, 1-Ring
  4. Drug

    Sapropterin

    go.drugbank.com/drugs/DB00360
    ApprovedInvestigational

    Sapropterin (tetrahydrobiopterin or BH4) is a cofactor in the synthesis of nitric oxide. It is also essential in the conversion of phenylalanine to tyrosine by the enzyme phenylalanine-4-hydroxylase; the conversion of tyrosine to L-dopa ...

    Synonyms: 2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone, (−)-(6R)-2-amino-6-((1R,2S)-1,2-dihydroxypropyl)-5,6,7,8-tetrahydro-4(3H)-pteridinoneProducts: KUVAN® 100 MG, KUVAN 100 MG ÇÖZÜNEBİLİR TABLET, 120 ADET
  5. Drug

    Hydroxyurea

    go.drugbank.com/drugs/DB01005
    ApprovedInvestigational

    Hydroxyurea is a non-alkylating antineoplastic agent that was first synthesized in 1869 but was not characterized biologically until 1928. It was first approved by the FDA in 1998 for the treatment of sickle cell anemia in adults. Althou...

    Products: SIKLOS® 100 MG COMPRIMIDOS, Hydroxycarbamid 1A Pharma 100 mg - Filmtabletten
  6. Drug

    Interferon alfa-n1

    go.drugbank.com/drugs/DB00011
    ApprovedWithdrawn

    Interferon alfa-n1 consists of purified, natural (n is for natural) alpha interferon subtypes, at least two of which are glycosylated. This differs from recombinant alpha interferons, which are individual non-glycosylated proteins produc...

    Products: WELLFERON INYECTABLE 10 MU/ML., Wellferon Inj 10 000 000unit/ml
  7. Drug

    Zinc oxide

    go.drugbank.com/drugs/DB09321
    ApprovedInvestigational

    Zinc oxide is an inorganic compound used in a number of manufacturing processes. It can be found in rubbers, plastics, ceramics, glass, cement, lubricants, paints, ointments, adhesives, sealants, pigments, foods, batteries, ferrites, fir...

    Mixtures: Calcium Mg and Zn Capsules With Vitamin D, PreQue 10Products: Lipshade SPF 30 Lucky Me, Triple Care Cream 10%
  8. Drug

    Metandienone

    go.drugbank.com/drugs/DB13586
    ApprovedWithdrawn

    Metandienone is an orally active anabolic androgenic steroid. It was introduced to the market in the 1960s but later discontinued and withdrawn from the market. Although it is prohibited in and outside competition by the World Anti-Dopin...

    Products: SIROBOLIN ŞURUP, 120 ML, เมเทน 10
  9. Drug

    Nitrazepam

    go.drugbank.com/drugs/DB01595
    Approved

    A benzodiazepine derivative used as an anticonvulsant and hypnotic.

    Synonyms: 2,3-dihydro-7-nitro-5-phenyl-1H-1,4-benzodiazepin-2-one, 7-nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-oneProducts: NITRAZEPAM-NEURAX 10 MG, Nitrazepam-10
  10. Drug

    Insulin lispro

    go.drugbank.com/drugs/DB00046
    ApprovedInvestigational

    Marketed as the brand name product Humalog, insulin lispro begins to exert its effects within 15 minutes of subcutaneous administration, while peak levels occur 30 to 90 minutes after administration. … Insulin lispro is a rapid-acting form of insulin used for the treatment of hyperglycemia caused by Type 1 and Type 2 Diabetes.

    Mixtures: HUMALOG MIX25 KWIKPEN 100 units/ml, HUMALOG MIX25 KWIKPEN 100 units/mlProducts: HUMALOG 100 IU/ML 10 ML ÇÖZELTİ İÇEREN FLAKON, 1 ADET, HUMALOG MIX 25 100 IU/ML 10 ML SUSPANSIYON ICEREN FLAKON, 1 ADET